发明名称 Methods for administering weight loss medications
摘要 Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.
申请公布号 US9125868(B2) 申请公布日期 2015.09.08
申请号 US201414220349 申请日期 2014.03.20
申请人 OREXIGEN THERAPEUTICS, INC. 发明人 McKinney Anthony A.;Tollefson Gary;Weber Eckard;Soltero Rick
分类号 A61K9/20;A61K31/415;A61K31/137;A61K31/439;A61K31/35;A61K31/551;A61P3/04;A61K31/138;A61J1/03;A61J7/04;A61K31/135;A61K31/42;A61K31/485;A61K45/06;A61K31/423;A61K9/24 主分类号 A61K9/20
代理机构 Knobbe, Martens, Olson & Bear LLP 代理人 Knobbe, Martens, Olson & Bear LLP
主权项 1. A method of administering a pharmaceutical formulation to an individual, comprising: administering a first amount of a pharmaceutical formulation every day for a first week, wherein the first amount of a pharmaceutical formulation comprises about 90 mg of bupropion and an amount of naltrexone selected from the group consisting of about 4 mg and about 8 mg; administering a second amount of a pharmaceutical formulation every day for a second week, wherein the second amount of a pharmaceutical formulation comprises bupropion and naltrexone, and wherein the second amount of a pharmaceutical formulation comprises about twice as much bupropion and about twice as much naltrexone as the first amount of a pharmaceutical formulation; administering a third amount of a pharmaceutical formulation every day for a third week, wherein the third amount of a pharmaceutical formulation comprises bupropion and naltrexone, and wherein the third amount of a pharmaceutical formulation comprises about three times as much bupropion and about three times as much naltrexone as the first amount of a pharmaceutical formulation; and administering a fourth amount of a pharmaceutical formulation every day for a fourth week, wherein the fourth amount of a pharmaceutical formulation comprises bupropion and naltrexone, and wherein the fourth amount of a pharmaceutical formulation comprises about four times as much bupropion and about four times as much naltrexone as the first amount of a pharmaceutical formulation.
地址 La Jolla CA US